- Home
- MOVE vs ANVS Comparison
MOVE vs ANVS Comparison
Compare MOVE & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOVE
- ANVS
- Stock Information
- Founded
- MOVE 2018
- ANVS 2008
- Country
- MOVE United States
- ANVS United States
- Employees
- MOVE N/A
- ANVS N/A
- Industry
- MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- MOVE Health Care
- ANVS Health Care
- Exchange
- MOVE Nasdaq
- ANVS Nasdaq
- Market Cap
- MOVE 7.3M
- ANVS 24.2M
- IPO Year
- MOVE 2021
- ANVS 2020
- Fundamental
- Price
- MOVE $0.86
- ANVS $1.57
- Analyst Decision
- MOVE Buy
- ANVS Strong Buy
- Analyst Count
- MOVE 1
- ANVS 5
- Target Price
- MOVE $30.00
- ANVS $37.00
- AVG Volume (30 Days)
- MOVE 45.3K
- ANVS 453.8K
- Earning Date
- MOVE 04-09-2025
- ANVS 05-12-2025
- Dividend Yield
- MOVE N/A
- ANVS N/A
- EPS Growth
- MOVE N/A
- ANVS N/A
- EPS
- MOVE N/A
- ANVS N/A
- Revenue
- MOVE $1,013,000.00
- ANVS N/A
- Revenue This Year
- MOVE $1,460.71
- ANVS N/A
- Revenue Next Year
- MOVE N/A
- ANVS N/A
- P/E Ratio
- MOVE N/A
- ANVS N/A
- Revenue Growth
- MOVE N/A
- ANVS N/A
- 52 Week Low
- MOVE $0.71
- ANVS $1.11
- 52 Week High
- MOVE $8.85
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- MOVE 21.11
- ANVS 50.94
- Support Level
- MOVE $0.78
- ANVS $1.19
- Resistance Level
- MOVE $0.99
- ANVS $1.68
- Average True Range (ATR)
- MOVE 0.17
- ANVS 0.17
- MACD
- MOVE 0.09
- ANVS 0.07
- Stochastic Oscillator
- MOVE 26.01
- ANVS 76.67
About MOVE Movano Inc.
Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.